AMERISAFE (AMSF)
(Delayed Data from NSDQ)
$54.95 USD
+1.14 (2.12%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $54.91 -0.04 (-0.07%) 7:52 PM ET
2-Buy of 5 2
D Value F Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$54.95 USD
+1.14 (2.12%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $54.91 -0.04 (-0.07%) 7:52 PM ET
2-Buy of 5 2
D Value F Growth B Momentum F VGM
Zacks News
Can Amerisafe Grow on the Back of Rising Net Premiums?
by Zacks Equity Research
Amerisafe (AMSF) is well poised to rise on solid net premiums growth.
Amerisafe (AMSF) Down 0.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Amerisafe (AMSF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Amerisafe (AMSF) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Amerisafe (AMSF) delivered earnings and revenue surprises of 26.03% and 3.55%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks Poised to Emerge Winners in Q2 Earnings
by Zacks Equity Research
Lower cat loss, pricing gains, increasing interest rate environment and solid capital levels should aid insurers' Q2 earnings.
AIG to Report Q2 Earnings: Is Disappointment in Store?
by Zacks Equity Research
AIG's earnings should suffer from underwriting loss as it is taking several initiatives for business realignment.
Accident and Health Insurers Outlook: High Medical Costs Hurt
by Tanuka De
Accident and Health Insurance industry should benefit from strengthening of economy, fueling demand for workers' compensation insurance. However, increasing medical costs pose a challenge.
Can Nasdaq (NDAQ) Keep Earnings Beat Streak Alive in Q2?
by Zacks Equity Research
Nasdaq's (NDAQ) second quarter is likely to benefit from improvement in trading business.
Will Aflac's (AFL) Earnings Suffer From Weak Japan Revenue?
by Zacks Equity Research
Aflacs (AFL) Q2 earnings set to gain from higher U.S segment revenues, partly offset by lower Japan revenues and high costs.
AMERISAFE & Units Receive Rating Actions From A.M. Best
by Zacks Equity Research
A.M. Best revises the credit ratings of AMERISAFE (AMSF) and its subsidiaries along with updated outlooks.
Unum Group (UNM) Q1 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Unum Group (UNM) Q1 earnings gain traction from higher premiums, stable benefits experience and a lower tax rate.
Amerisafe (AMSF) Q1 Earnings Top Estimates on Lower Expenses
by Zacks Equity Research
Amerisafe's (AMSF) Q1 earning upside was driven by an increase in net investment income and a decline in total expenses.
Why Is AMERISAFE (AMSF) Down 6.6% Since Its Last Earnings Report?
by Zacks Equity Research
AMERISAFE (AMSF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Get Rid of Amerisafe (AMSF) Now?
by Zacks Equity Research
It seems to be a wise decision for investors to drop Amerisafe (AMSF) stock considering its negative estimate revision, price depreciation as well as unfavorable Zacks rank.
New Strong Sell Stocks for March 6th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Amerisafe's (AMSF) Q4 Earnings Miss as Revenues Decline
by Zacks Equity Research
Amerisafe's (AMSF) earnings suffer from a decline in revenues and increase in expenses.
Marsh & McLennan (MMC) Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
Decent performance across segments is likely to drive Marsh & McLennan's (MMC) fourth-quarter results.
What's in Store for MetLife (MET) This Earnings Season?
by Zacks Equity Research
MetLife's (MET) earnings should be driven by higher contribution from its U.S. EMEA, Latin America businesses, partly offset by lower net income from the Asia unit.
Will Weak Japan Business Hurt Aflac's (AFL) Q4 Earnings?
by Zacks Equity Research
Aflac's (AFL) earnings should see a dent from weak Japan business but be partially aided by strength in its U.S. business.
Will Annuities Unit Aid Lincoln National (LNC) Q4 Earnings?
by Zacks Equity Research
Lincoln National's (LNC) earnings are likely to benefit from higher annuity sales, strong Retirement and Life insurance business.
Aflac (AFL) Hits New 52-Week High: Is More Upside Left?
by Zacks Equity Research
Aflac (AFL) gains on estimated positive impact of tax reform but further upside seems muted.
Why You Shouldn't Bet Against AMERISAFE (AMSF) Stock
by Zacks Equity Research
AMERISAFE, Inc. (AMSF) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.
Is Amerisafe (AMSF) a Great Stock for Value Investors?
by Zacks Equity Research
Is Amerisafe (AMSF) a great pick from the value investor's perspective right now? Read on to know more.
Why the Earnings Streak Will Continue for Amerisafe (AMSF)
by Zacks Equity Research
Amerisafe (AMSF) boasts a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
Amerisafe Maintains Niche Position in High Hazard Insurance
by Zacks Equity Research
Amerisafe's (AMSF) niche presence in workers' compensation insurance market operating high-hazard industries makes it a specialty insurer.
Unum (UNM) Rides High on Growth Prospects: Time to Buy?
by Zacks Equity Research
Unum (UNM) appears an attractive pick on the back of growth projections and upward estimate revisions.